Nantahala Capital Management, LLC 13F holdings, Q1 2026
Holdings as of March 31, 2026 · filings on SEC EDGAR · latest filing →
Nantahala Capital Management, LLC disclosed 130 US equity positions worth $1.6bn in its Q1 2026 13F filing. The largest position was TBBK at 4.6% of the reported book, followed by HGV and SLNOEUR.
What did Nantahala Capital Management, LLC own in Q1 2026? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | TBBK BANCORP INC DEL | Financial Services | 4.6% | $74.2m | 1,380,456 | – | |
| 2 | HGV HILTON GRAND VACATIONS INC | Consumer Cyclical | 3.7% | $59.2m | 1,513,656 | – | |
| 3 | SLNOEUR SOLENO THERAPEUTICS INC | 3.6% | $58.4m | 1,744,124 | – | ||
| 4 | BVS BIOVENTUS INC | Healthcare | 3.5% | $55.9m | 6,122,403 | – | |
| 5 | PTON PELOTON INTERACTIVE INC | Consumer Cyclical | 3.2% | $51.5m | 12,000,000 | – | |
| 6 | ESTA ESTABLISHMENT LABS HLDGS INC | Healthcare | 3.0% | $47.3m | 832,956 | – | |
| 7 | SVRA SAVARA INC | Healthcare | 2.5% | $40.1m | 7,344,783 | – | |
| 8 | XTNT XTANT MED HLDGS INC | 2.4% | $38.2m | 68,394,000 | – | ||
| 9 | GOGO GOGO INC | Communication Services | 2.2% | $35.7m | 8,882,036 | – | |
| 10 | AMRX AMNEAL PHARMACEUTICALS INC | Healthcare | 2.2% | $35.4m | 2,844,108 | – | |
| 11 | AVR ANTERIS TECHNOLOGIES GLOBAL | 1.9% | $30.7m | 5,530,910 | – | ||
| 12 | ETON ETON PHARMACEUTICALS INC | 1.8% | $29.0m | 1,175,951 | – | ||
| 13 | EOLS EVOLUS INC | Healthcare | 1.6% | $26.2m | 6,376,857 | – | |
| 14 | TNGX TANGO THERAPEUTICS INC | Healthcare | 1.6% | $26.2m | 1,250,452 | – | |
| 15 | LB PHARMACEUTICALS INC | 1.6% | $26.0m | 1,052,894 | – | ||
| 16 | FOXF FOX FACTORY HLDG CORP | Consumer Cyclical | 1.5% | $24.5m | 1,488,300 | – | |
| 17 | MLYS MINERALYS THERAPEUTICS INC | Healthcare | 1.5% | $24.3m | 895,481 | – | |
| 18 | ZVRA ZEVRA THERAPEUTICS INC | 1.5% | $23.5m | 2,521,936 | – | ||
| 19 | FULC FULCRUM THERAPEUTICS INC | Healthcare | 1.5% | $23.4m | 3,050,040 | – | |
| 20 | FOSL FOSSIL GROUP INC | Consumer Cyclical | 1.5% | $23.3m | 5,404,024 | – | |
| 21 | RDNW RIDENOW GROUP INC | 1.4% | $23.1m | 3,272,845 | – | ||
| 22 | ABEO ABEONA THERAPEUTICS INC | Healthcare | 1.4% | $22.5m | 5,013,052 | – | |
| 23 | CWH CAMPING WORLD HLDGS INC | Consumer Cyclical | 1.4% | $22.3m | 3,259,274 | – | |
| 24 | ADCT ADC THERAPEUTICS SA | Healthcare | 1.3% | $21.0m | 5,597,433 | – | |
| 25 | TITN TITAN MACHY INC | Industrials | 1.3% | $21.0m | 1,254,520 | – | |
| 26 | HLF HERBALIFE LTD | Consumer Defensive | 1.2% | $19.9m | 1,353,653 | – | |
| 27 | IMAX IMAX CORP | Communication Services | 1.2% | $19.6m | 515,554 | – | |
| 28 | VSTM VERASTEM INC | Healthcare | 1.2% | $19.0m | 3,584,820 | – | |
| 29 | BCRX BIOCRYST PHARMACEUTICALS INC | Healthcare | 1.2% | $18.9m | 1,987,397 | – | |
| 30 | AVTX AVALO THERAPEUTICS INC | Healthcare | 1.2% | $18.4m | 1,235,000 | – | |
| 31 | RMR RMR GROUP INC | 1.1% | $17.8m | 1,147,902 | – | ||
| 32 | RYAM RAYONIER ADVANCED MATLS INC | Basic Materials | 1.1% | $17.7m | 1,600,000 | – | |
| 33 | GERN GERON CORP | Healthcare | 1.0% | $16.7m | 11,225,000 | – | |
| 34 | BENITEC BIOPHARMA INC | 1.0% | $15.3m | 1,438,371 | – | ||
| 35 | ABVX ABIVAX SA | Healthcare | 1.0% | $15.3m | 137,237 | – | |
| 36 | ITGR INTEGER HLDGS CORP | Healthcare | 0.9% | $15.1m | 172,000 | – | |
| 37 | KROS KEROS THERAPEUTICS INC | Healthcare | 0.9% | $15.0m | 1,360,419 | – | |
| 38 | JACK JACK IN THE BOX INC | Consumer Cyclical | 0.9% | $14.9m | 1,542,715 | – | |
| 39 | JCAP JEFFERSON CAPITAL INC | 0.9% | $14.4m | 750,000 | – | ||
| 40 | AURA AURA BIOSCIENCES INC | 0.9% | $14.2m | 2,117,697 | – | ||
| 41 | USNA USANA HEALTH SCIENCES INC | Consumer Defensive | 0.9% | $14.2m | 810,074 | – | |
| 42 | PCVX VAXCYTE INC | Healthcare | 0.9% | $13.9m | 238,746 | – | |
| 43 | MDXG MIMEDX GROUP INC | Healthcare | 0.8% | $13.4m | 3,397,299 | – | |
| 44 | AH30 ASSERTIO HOLDINGS INC | 0.8% | $13.2m | 692,335 | – | ||
| 45 | DSGR DISTRIBUTION SOLUTIONS GRP I | 0.8% | $13.0m | 494,581 | – | ||
| 46 | AGOMAB THERAPEUTICS NV | 0.8% | $12.9m | 1,200,000 | – | ||
| 47 | HELIX ACQUISITION CORP III | 0.8% | $12.7m | 1,250,000 | – | ||
| 48 | APYX APYX MEDICAL CORPORATION | Healthcare | 0.8% | $12.7m | 3,440,304 | – | |
| 49 | SLN SILENCE THERAPEUTICS PLC | 0.7% | $11.3m | 2,146,731 | – | ||
| 50 | JANX JANUX THERAPEUTICS INC | Healthcare | 0.7% | $11.3m | 809,914 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.